首页> 外文期刊>Cureus. >Dosimetric Comparison of Stereotactic Body Radiotherapy and Intensity-Modulated Radiotherapy to Deliver Hypofractionated Radiotherapy in Organ-Confined Prostate Cancer
【24h】

Dosimetric Comparison of Stereotactic Body Radiotherapy and Intensity-Modulated Radiotherapy to Deliver Hypofractionated Radiotherapy in Organ-Confined Prostate Cancer

机译:立体定向身体放疗和调强放疗在器官受限的前列腺癌中进行低分割放疗的剂量学比较

获取原文
       

摘要

We compared the dose conformity, homogeneity, dose to organs at risk, and remaining volume at risk of two radiotherapy techniques --stereotactic body radiotherapy and intensity-modulated radiotherapy (IMRT) to deliver hypofractionated radiotherapy in organ-confined prostate cancer. Eleven successive patients treated on the CyberKnife stereotactic robotic radiosurgical system were taken up for this study. The CT images, including the structures contoured, were imported through DICOM RT from the Multiplan (Accuray Inc., Sunnyvale, CA, USA) treatment planning system to the Plato Sunrise treatment planning system (Nucletron, The Netherlands) for creating IMRT treatment plans on the Linac. Treatment planning was done for five?fractions, each fraction prescribed to a dose of 7.25 Gy to the planning target volume. Dose volume histograms were generated for the CyberKnife and Linac treatments for comparison. As per our protocol, a plan was considered adequate if at least 95% of planning target volume received the prescribed dose and satisfied the following constraints: a) volume of the rectum receiving 36Gy (V36) to 1cc and b) volume of the bladder receiving 37Gy (V37) to 10cc. Both the treatment techniques plans resulted in adequate planning target volume coverage (p value for D95, D90, D5, and V100% was 0.402, 0.97, 0.013, and?0.012, respectively). CyberKnife plans were more conformal (p value 0.001). Remaining volume at risk dose was significantly less in all CyberKnife plans at [V100% (p=0.01), V95% (p=.004), V90% (p=.001), V80% (p=0.02), V70 (p=0.03), V40% (p=0.021), and?V30% (p=0.001)] dose levels. The mean dose to rectum was lower in the CyberKnife plans (The p value for V100%, V80%, V50% and V30% dose levels was 0.02, 0.0001, 0.0002, and?0.12, respectively).
机译:我们比较了两种放疗技术-立体定向放疗和强度调节放疗(IMRT)的剂量一致性,均一性,处于危险中的器官的剂量以及处于危险中的剩余体积,以在器官受限的前列腺癌中提供超分割放疗。连续11例在Cyber​​Knife立体定向机器人放射外科手术系统上接受治疗的患者接受了这项研究。 CT图像(包括轮廓化的结构)通过DICOM RT从Multiplan(Accuray Inc.,美国加利福尼亚州,森尼韦尔,Accuray公司)治疗计划系统导入到Plato Sunrise治疗计划系统(荷兰,Nucletron),以在其上创建IMRT治疗计划。直线加速器。对五个部分进行了治疗计划,每个部分的处方剂量为计划目标量的7.25 Gy。生成了射波刀和直线加速器治疗的剂量体积直方图,以进行比较。根据我们的协议,如果至少有95%的计划目标体积接受了规定剂量并满足以下限制,则该计划就被认为是足够的:a)接受36Gy(V36)至<1cc的直肠体积,以及b)膀胱体积接收37Gy(V37)至<10cc两种处理技术计划均导致足够的计划目标体积覆盖率(D95,D90,D5和V100%的p值分别为0.402、0.97、0.013和?0.012)。射波刀计划更加保形(p值0.001)。在所有“射波刀”计划中,处于风险剂量下的剩余体积显着减少,分别为[V100%(p = 0.01),V95%(p = .004),V90%(p = .001),V80%(p = 0.02),V70( p = 0.03),V40%(p = 0.021)和?V30%(p = 0.001)]剂量水平。在“射波刀”计划中,直肠的平均剂量较低(V100%,V80%,V50%和V30%剂量水平的p值分别为0.02、0.0001、0.0002和0.12)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号